Breast Cancer Clinical Trial
Official title:
A Comparison Study of Breast Tomosynthesis Images Reconstructed at 1 Millimeter and 5 Millimeter Slice Thicknesses
| Verified date | November 2013 |
| Source | Emory University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Institutional Review Board |
| Study type | Observational |
Early diagnosis is one of the most important factors in the survival of patients diagnosed
with breast cancer. To aid in the early detection of breast cancer, a new technology, called
tomosynthesis imaging is being developed. The idea behind tomosynthesis imaging is to "look"
at the breast from different points of view by obtaining x-ray flat images from different
angles while the breast does not move, and then mathematically combine these flat images
into a three-dimensional image. The benefit of these three dimensional images is that the
radiologist can look at the different tissues of the breast in their real positions, as
opposed to all the tissues being "flattened" into a flat image, like that of a normal
mammogram. Since tomosynthesis images of the breast show the tissues in their real position,
the radiologist should be able to more easily find a tumor and also be able to reduce the
number of time he or she thinks there is a tumor present when in reality there is not one
there.
Before this new technology can be used in the clinic routinely, it is necessary to perform a
large number of studies to find the optimal way to use it. In this study, the investigators
are aiming to find how thick the slices or layers representing the breast should be in the
image when shown to the radiologist. The difference between these two thicknesses in how
useful the images are to the radiologist could be important. The investigators are trying to
determine if slicing the image of the breast into thicker slices will make the job of the
radiologist easier or not when deciding to recommend or not a biopsy (laboratory analysis)
of what the previous mammogram found. To find the answer to this question, the investigators
will image patients with their tomosynthesis machine and look at the tomosynthesis images
with the thin and thick slices. The radiologists that read each image will decide if they
would have recommended the patient to get a biopsy based only in each of these images. The
recommendations based on the images with thin slices and the recommendations based on the
images with thick slices will be compared with what was actually recommended using the
standard clinical tests. The investigators hope to find that the thicker slices help more
than the thinner slices when trying to decide if biopsy is needed or not.
| Status | Completed |
| Enrollment | 182 |
| Est. completion date | December 2012 |
| Est. primary completion date | September 2011 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Female |
| Age group | 35 Years and older |
| Eligibility |
3.1 Eligibility Criteria All subjects will be women at least 35 years of age that have
been found, after diagnostic workup, to have focal distributions of microcalcifications
(BI-RADS 3, 4 or 5), focal soft tissue lesions (BI-RADS 3, 4 or 5), or no findings
(BI-RADS 1). 3.2 Ineligibility Criteria - Subject does not meet any of the inclusion criteria - Women with suspected or confirmed pregnancy - Women who have had bilateral mastectomy - Women with large breasts that cannot be accommodated within the field of view of the tomosynthesis system - Women who are very frail and unable to cooperate - Women who are under 35 years of age - Women who cannot give informed consent - Male subjects - Women with implants - Subject has had breast augmentation, except for unilateral augmentation done for prior mastectomy |
Observational Model: Case Control, Time Perspective: Retrospective
| Country | Name | City | State |
|---|---|---|---|
| United States | Emory University Hospital Breast Imaging Center | Atlanta | Georgia |
| Lead Sponsor | Collaborator |
|---|---|
| Emory University | Hologic, Inc. |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Equivalence in diagnostic accuracy | After biopsy or follow-up | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |